<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120389</url>
  </required_header>
  <id_info>
    <org_study_id>xuwen2019-929</org_study_id>
    <nct_id>NCT04120389</nct_id>
  </id_info>
  <brief_title>Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Complicated and Combined Cataract Surgery</brief_title>
  <official_title>Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Complicated and Combined Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the efficacy of an ocular bandage contact lens for the treatment of dry eye after
      complicated and combined cataract surgery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2020</start_date>
  <completion_date type="Anticipated">April 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular Surface Disease Index questionnaire</measure>
    <time_frame>0 day preoperatively</time_frame>
    <description>Ocular Surface Disease Index questionnaire were included 12 questions，and each was rated from 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular Surface Disease Index questionnaire</measure>
    <time_frame>1 day postoperatively</time_frame>
    <description>Ocular Surface Disease Index questionnaire were included 12 questions，and each was rated from 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular Surface Disease Index questionnaire</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>Ocular Surface Disease Index questionnaire were included 12 questions，and each was rated from 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular Surface Disease Index questionnaire</measure>
    <time_frame>1 month postoperatively</time_frame>
    <description>Ocular Surface Disease Index questionnaire were included 12 questions，and each was rated from 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular Surface Disease Index questionnaire</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>Ocular Surface Disease Index questionnaire were included 12 questions，and each was rated from 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tear Breakup Time</measure>
    <time_frame>0 day preoperatively</time_frame>
    <description>Tear Breakup Time was performed to assess tear film stability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tear Breakup Time</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>Tear Breakup Time was performed to assess tear film stability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tear Breakup Time</measure>
    <time_frame>1 month postoperatively</time_frame>
    <description>Tear Breakup Time was performed to assess tear film stability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tear Breakup Time</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>Tear Breakup Time was performed to assess tear film stability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>0 day preoperatively</time_frame>
    <description>The Schirmer test was performed by inserting a test strip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>The Schirmer test was performed by inserting a test strip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>1 month postoperatively</time_frame>
    <description>The Schirmer test was performed by inserting a test strip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>The Schirmer test was performed by inserting a test strip</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective symptoms</measure>
    <time_frame>0 day preoperatively</time_frame>
    <description>Subjective symptoms evaluation related to 11 ocular symptoms ，and each was graded as follows：0 never、1 occasional、2 often、3 always</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective symptoms</measure>
    <time_frame>1 day postoperatively</time_frame>
    <description>Subjective symptoms evaluation related to 11 ocular symptoms ，and each was graded as follows：0 never、1 occasional、2 often、3 always</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective symptoms</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>Subjective symptoms evaluation related to 11 ocular symptoms ，and each was graded as follows：0 never、1 occasional、2 often、3 always</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective symptoms</measure>
    <time_frame>1 month postoperatively</time_frame>
    <description>Subjective symptoms evaluation related to 11 ocular symptoms ，and each was graded as follows：0 never、1 occasional、2 often、3 always</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective symptoms</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>Subjective symptoms evaluation related to 11 ocular symptoms ，and each was graded as follows：0 never、1 occasional、2 often、3 always</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluorescein Staining</measure>
    <time_frame>0 day preoperatively</time_frame>
    <description>The corneal surface was divided into four regions, and each region was scored as follows: 0, no staining; 1, between one and three dots; 2, less than five dots; and 3, bulk or strip staining. The four regions scores were then added to obtain a final score for the eye</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluorescein Staining</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>The corneal surface was divided into four regions, and each region was scored as follows: 0, no staining; 1, between one and three dots; 2, less than five dots; and 3, bulk or strip staining. The four regions scores were then added to obtain a final score for the eye</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluorescein Staining</measure>
    <time_frame>1 month postoperatively</time_frame>
    <description>The corneal surface was divided into four regions, and each region was scored as follows: 0, no staining; 1, between one and three dots; 2, less than five dots; and 3, bulk or strip staining. The four regions scores were then added to obtain a final score for the eye</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluorescein Staining</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>The corneal surface was divided into four regions, and each region was scored as follows: 0, no staining; 1, between one and three dots; 2, less than five dots; and 3, bulk or strip staining. The four regions scores were then added to obtain a final score for the eye</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>0 day preoperatively</time_frame>
    <description>The BCVA was measured by the same optometrist at each visit</description>
  </other_outcome>
  <other_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>1 day postoperatively</time_frame>
    <description>The BCVA was measured by the same optometrist at each visit</description>
  </other_outcome>
  <other_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>1 week postoperatively</time_frame>
    <description>The BCVA was measured by the same optometrist at each visit</description>
  </other_outcome>
  <other_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>1 month postoperatively</time_frame>
    <description>The BCVA was measured by the same optometrist at each visit</description>
  </other_outcome>
  <other_outcome>
    <measure>Best Corrected Visual Acuity</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>The BCVA was measured by the same optometrist at each visit</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cataract</condition>
  <condition>Lens Subluxation</condition>
  <condition>Hypermature Cataract</condition>
  <condition>Corneal Opacity</condition>
  <condition>Small Pupil</condition>
  <arm_group>
    <arm_group_label>BCL group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bandage contact lenses(PureVision; Bausch &amp; Lomb Inc., Rochester, NY)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bandage contact lenses(PureVision; Bausch &amp; Lomb Inc., Rochester, NY)</intervention_name>
    <description>wear an bandage contact lenses for a week after Complicated and Combined cataract surgery.</description>
    <arm_group_label>BCL group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification</intervention_name>
    <description>underwent standard phacoemulsification through a 2.8-mm clear corneal temporal incision and intraocular lens</description>
    <arm_group_label>BCL group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. cataract patients（age 40-80）

          2. complex symptom（such as:corneal opacity、small pupil、zonule relaxationlens
             subluxation、Shallow Anterior Chamber、hypermature cataract、hard nucleus,etc）

          3. dry eye disease

        Exclusion Criteria:

          1. simplex age-related cataract

          2. contact lens use

          3. ocular therapies such as 0.05% cyclosporine A or steroids in the last 3 months

          4. any systemic diseases such as heart diseases, diabetes and psychosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>wen xu, PHD</last_name>
    <phone>+86 571 87783897</phone>
    <email>xuwen2003@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Affiliated Hospital, Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>wen xu, PHD</last_name>
      <phone>+86 571 87783897</phone>
      <email>xuwen2003@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bandage contact lens</keyword>
  <keyword>cataract surgery</keyword>
  <keyword>dry eye</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Miosis</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Corneal Opacity</mesh_term>
    <mesh_term>Lens Subluxation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

